Glypican-3–Targeting F(ab′)2 for 89Zr PET of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Glypican-3–Targeting F(ab′)2 for 89Zr PET of Hepatocellular Carcinoma

Published:2014-10-30 Issue:12 Volume:55 Page:2032-2037
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Sham Jonathan G.,Kievit Forrest M.,Grierson John R.,Chiarelli Peter A.,Miyaoka Robert S.,Zhang Miqin,Yeung Raymond S.,Minoshima Satoshi,Park James O.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference43 articles.

1. Hepatocellular Carcinoma (HCC)

2. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. International Agency for Research on Cancer website. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed October 1, 2014.

3. National Comprehensive Cancer Network. Hepatobiliary Cancers Version 2.2014. National Comprehensive Cancer Network website. http://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf. Accessed October 1, 2014.

4. ACR. LI-RADS v2013.1. ACR website. http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/LIRADS/lirads%20v20131.pdf. Accessed September 22, 2014.

5. CT and MRI of hepatocellular carcinoma: an update

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor;Bioorganic Chemistry;2024-06

2. Preclinical Evaluation of ^99mTc-MAG₃-5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with ^99mTc-MAG₃-5-F(ab′)₂;Molecular Pharmaceutics;2023-12-18

3. Radioiodine based biomedical carriers for cancer theranostics;Coordination Chemistry Reviews;2023-12

4. Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma;EJNMMI Research;2023-04-27

5. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET;Journal of Nuclear Medicine;2023-03-30